Cargando…
Gene Expression-Based Signature Can Predict Sorafenib Response in Kidney Cancer
Sorafenib is a tyrosine kinase inhibitory drug with multiple molecular specificities that is approved for clinical use in second-line treatments of metastatic and advanced renal cell carcinomas (RCCs). However, only 10–40% of RCC patients respond on sorafenib-containing therapies, and personalizatio...
Autores principales: | Gudkov, Alexander, Shirokorad, Valery, Kashintsev, Kirill, Sokov, Dmitriy, Nikitin, Daniil, Anisenko, Andrey, Borisov, Nicolas, Sekacheva, Marina, Gaifullin, Nurshat, Garazha, Andrew, Suntsova, Maria, Koroleva, Elena, Buzdin, Anton, Sorokin, Maksim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963850/ https://www.ncbi.nlm.nih.gov/pubmed/35359606 http://dx.doi.org/10.3389/fmolb.2022.753318 |
Ejemplares similares
-
Experimental and Meta-Analytic Validation of RNA Sequencing Signatures for Predicting Status of Microsatellite Instability
por: Sorokin, Maksim, et al.
Publicado: (2021) -
Human Blood Serum Can Diminish EGFR-Targeted Inhibition of Squamous Carcinoma Cell Growth through Reactivation of MAPK and EGFR Pathways
por: Kamashev, Dmitri, et al.
Publicado: (2023) -
RNA Sequencing in Comparison to Immunohistochemistry for Measuring Cancer Biomarkers in Breast Cancer and Lung Cancer Specimens
por: Sorokin, Maxim, et al.
Publicado: (2020) -
Machine Learning Applicability for Classification of PAD/VCD Chemotherapy Response Using 53 Multiple Myeloma RNA Sequencing Profiles
por: Borisov, Nicolas, et al.
Publicado: (2021) -
Retroelement—Linked Transcription Factor Binding Patterns Point to Quickly Developing Molecular Pathways in Human Evolution
por: Nikitin, Daniil, et al.
Publicado: (2019)